Score Breakdown
Offering Ability
26
Cash Runway
40
Float Risk
32
Warrant Exposure
15
Convertible Debt
15
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CNTA.
Market Data
Market Cap$6.15B
Shares Outstanding154.73M
Float92.48M
Cash$276.59M
Debt$116.07M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 18.6% shares (2026Q1 vs prior)
162 institutional holders · 177.48M shares
#1
Avoro Capital Advisors LLC
25.99M shares
#2
Medicxi Ventures Management (Jersey) Ltd
19.96M shares
#3
PERCEPTIVE ADVISORS LLC
10.52M shares
+ 17 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2022-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual CNTA Dilution Snapshot
Centessa Pharmaceuticals plc (CNTA) has a DilutionScore of 28/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CNTA: xbrl on 2022-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: